If doxycycline (100 mg, 2 times/d) combined with rifampicin (600 mg/d) was used for 2 weeks but the ESR and CRP did not decrease, there was brucellal drug resistance, or if the patient had other kinds of infections, there was a high risk of recurrence. The gene discussed is CRP; the disease is infection.